Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The objective of this research is to check whether the test drug (lamivudine in the form of
coated tablet 150 mg) achieves plasma levels equivalent to those obtained from the EPIVIR in
the form of coated tablet 150 mg GlaxoSmithKline administered to 28 volunteers of both genres
under fasting condition.